News and Opinion
Find out more about GW4 AMR Alliance’s latest news and achievements.
WOULD YOU LIKE TO HEAR MORE FROM the GW4 AMR Alliance? SUBSCRIBE TO OUR NEWSLETTER.
AMR RESEARCH NEWS
- Arwain DGC wins Antibiotic Guardian 2022 Awards, supported by GW4 AMR Alliance researchers GW4 Alliance, May 2023
- GW4 Researchers use simulation games to help farmers recognise lameness (new publication) GW4 AMR Alliance, March 2023
- Tackling infections that pass from animals to humans (new doctoral training programme) Cardiff, January 2023
- Researchers take joint approach to tackling antimicrobial resistance Exeter, January 2023
- GW4 Researchers lead international team to investigate the spread of an antimicrobial resistance GW4, November 2022
- Feeding dogs raw meat associated with increased presence of antibiotic-resistant bacteria Bristol, July 2022
- Antimicrobial resistance study begins on Welsh farms Bristol, June 2022
- Inhaled antibiotics could help reduce antimicrobial resistance Bath, May 2022
- GW4 Generator Award: Seven Collaborative Research Communities Awarded £125k Funding (two new AMR research communities funded) GW4, May 2022
- Researchers discover drug-resistant environmental mould is capable of infecting people – Exeter, April 2022
READ MORE RESEARCH NEWS FROM:
University of Bristol and Bristol AMR
Cardiff University and the Antimicrobial Resistance and Infection Biology Network
University of Exeter and Exeter AMR network
OPINION PIECES
- THE COVID OUTBREAK AND AMR Dr Phil Mitchelmore, Clinical Lecturer at the University of Exeter, Honorary Consultant at Royal Devon & Exeter Hospital and GW4 Crucible 2020 Alumni reflects on AMR against the backdrop of the COVID crisis, and how GW4 and its Crucible Alumni are set to tackle this global challenge. For the last six months, the coronavirus (COVID-19) pandemic has eclipsed all other concerns, including antimicrobial resistance (AMR). However, while our hopes and expectations are that COVID-19 will be defeated in 2021, it is highly likely that AMR will continue to be the most significant threat to global health and global economy for the coming years.
- ONLINE EVENTS IN THE COVID-ERA: EXPERIENCE FROM THE EARLY CAREER SYMPOSIA SCHEME 2020 Dr Rebecca Weiser (Cardiff University), Dr Hannah Serrage, Dr Gemma Lasseter and Dr Charlie Colenso (University of Bristol) reflect on the challenges they faced delivering the ECR Symposium on ‘Multidisciplinary Approaches to AMR: Bench to Bedside and Beyond’ during a global pandemic, the skills they learnt and the new collaborations developed along the way.
- COVID-19 AND IMPLICATIONS FOR ANTIMICROBIAL RESISTANCE Dr Aimee Murray, Research Fellow at the University of Exeter and GW4 Crucible 2020 Alumni explores how the COVID-19 crisis could impact AMR in clinical and community settings, and explains why GW4 is well placed to research and help combat these significant global challenges.
